NCM · Medical - Healthcare Information Services

BEAT (BEAT) Stock

$0.50 +0.98% NCM: BEAT Healthcare

Valuation

MetricValue
Price$0.50
Market Cap$17.10M
P/E Ratio-1.48
P/B Ratio10.54
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$4.00
52-Week Low$0.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-700.00%
ROA-350.00%
ROCE-700.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio1.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-13.0M$-15.0M$-20.0M$-21.0M
Net Profit$-4.0M$-13.0M$-15.0M$-19.0M$-21.0M
EPS$-0.56$-1.59$-0.72$-0.73$-0.62
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$14.0M$4.0M$17.0M$3.0M$6.0M
Total Liabilities$1.0M$2.0M$1.0M$2.0M$3.0M
Cash$13.0M$4.0M$16.0M$2.0M$4.0M
Borrowings$0$0$0$0$0

Latest News

HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device Business Wire · Jul 14, 2026 HeartBeam (BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital NewMediaWire · Jul 1, 2026 HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule Business Wire · Jul 1, 2026 HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study NewMediaWire · Jun 30, 2026 HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp Simply Wall St. · Jun 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-10.0M$-12.0M$-14.0M$-14.0M
Investing Cash Flow$0$0$-1.0M$0$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$13.0M$-10.0M$13.0M$-14.0M$2.0M
Free Cash Flow$-3.0M$-10.0M$-12.0M$-15.0M$-15.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-46.15%
Quick Ratio0.70
Interest Coverage—
Return 1Y-47.19%
Return 3Y-79.44%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CRVO $2.56 -3.76% -1.09 $23.70M 0.00%
EQ $2.57 +3.21% -5.28 $91.29M 0.00%
HOWL $0.40 -3.04% -0.33 $19.54M 0.00%
INKTMiNK Therapeutics, Inc. $10.97 -0.95% -3.91 $54.63M 0.00%
IOBTIO Biotech, Inc. $0.01 -27.59% -0.01 $885690 0.00%

About BEAT

BEAT is led by CEO Robert Eno, publicly traded since 2021.

BEAT stock trades at $0.50 with a market capitalization of $17.10M. The stock is valued at a price-to-earnings (P/E) ratio of -1.48, price-to-book of 10.54, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.50 and $4.00, and currently trades 87.5% below its 52-week high.

On profitability, BEAT generates a return on equity (ROE) of -700.00%, return on capital employed of -700.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides